Impact of connecting tuberculosis directly observed therapy short-course with smoking cessation on health-related quality of life

Table 2 Health-related quality of life outcomes according to group assignment^a

HRQoL outcome measure	Control Group (DOTS)n = 46	Intervention Group(SCIDOTS)n = 40	t (df = 84)	p-value^b
EQ-5D utility index
Baseline	0.70 ± 0.31	0.72 ± 0.20	0.37	0.715
End of 3-months follow up	0.87 ± 0.22	0.91 ± 0.16	0.98	0.333
End of 6-months follow up	0.91 ± 0.14	0.98 ± 0.08	2.85	0.006
EQ-VAS
Baseline	57.04 ± 12.74	55.00 ± 13.83	-0.71	0.478
End of 3-months follow up	70.50 ± 13.62	73.60 ± 13.15	1.07	0.288
End of 6-months follow up	73.87 ± 12.01	87.28 ± 11.44	5.26	< 0.001

^aPlus-minus values are means ± SD; ^bp-values were calculated with the use of independent t-test for all continuous data reporting mean values
EQ-5D EuroQoL 5 dimensions; VAS visual analogue scale

ISSN: 1617-9625